Your kits leave your lab every day.You never hear back.Unless something goes wrong.

Gene expression and profiling (SYBR Green and probe-based), genotyping and SNP analysis, pathogen detection, miRNA quantification, and environmental qPCR. Clarida is built for standard singleplex and low-plex qPCR workflows across all major instrument platforms. Digital PCR (dPCR) support is on the roadmap - when it launches, Kit Intelligence partnerships extend to dPCR products automatically. No second negotiation. If your kits serve researchers doing any of these applications, we support them. Unsure whether your specific assay type fits? Bring it to the pilot call - that’s what it’s for.

Yes. Clarida’s analysis engine processes qPCR data the same way regardless of the regulatory label on the kit. If researchers use your products for gene expression, genotyping, pathogen surveillance, or similar research applications, Clarida handles the analysis and feeds your insights dashboard. To be precise: Clarida is a research analysis platform, not part of a validated IVD diagnostic workflow. But IVD-labeled kits used in research contexts are fully supported. If you’re unsure whether your product line fits, that’s a good question for the pilot call.

Yes - Kit Intelligence: Insights is built exactly for this. Researchers already use Clarida with your master mix. The data flows organically. You get a dashboard showing cross-instrument performance, lot consistency, and competitive positioning - without changing anything for the researcher. The alternative is commissioning CRO validation studies at €5,000-15,000 per instrument per formulation. Clarida gives you continuous field data for a fraction of the cost.

Your kit is the hero. Researchers select your kit by name during experiment setup. Your recommended settings load automatically. Both brands are visible - your kit name appears throughout the workflow, Clarida powers the analysis. Think Intel Inside: Clarida is the analysis engine inside your kit’s workflow. Your brand is what researchers see first.

That’s the idea. Start with one kit, one product line, one region. During the 90-day pilot, the platform fee and volume commitment are waived entirely. For Kit Intelligence: Insights, nothing else costs anything - your dashboard fills organically. For Kit Intelligence: Activate, you pay only for the analyses your researchers actually run - no floor, no minimum. If the dashboard doesn’t deliver at least one actionable insight for your product team, walk away. Nothing is locked in until you’ve seen the value.

This is the right question to ask. For Kit Intelligence: Activate, the answer is the mechanism itself: researchers pay nothing to analyze kit reactions, which removes the only barrier to first use. You don’t need Clarida to have existing users - you bring the users. Partners who announce the integration in a single email to their registered customer base typically see first experiments within two weeks. For Kit Intelligence: Insights, the model requires some existing organic usage of your product on the platform. That’s why we confirm data volume during the pilot before recommending Insights as your post-pilot product.

During the pilot, we measure actual adoption - how many of your kit buyers use Clarida for analysis. That data sets your volume commitment (no guessing). We’ll recommend which product fits: Kit Intelligence: Activate if you want to fund free analysis for researchers and accelerate data, or Kit Intelligence: Insights if your products already generate organic data on Clarida. Either way, cost is a platform fee plus a per kit reaction rate - it scales with your market presence, not a fixed tier. Partnerships run on 12-month agreements because building your kit intelligence takes investment from both sides. At renewal, 30 days notice either way. If you don’t renew, your dashboard is deactivated - no lock-in, no hostage data.

It depends on which product you choose. Kit Intelligence: Insights - the pilot is completely free. Platform fee and volume commitment waived for 90 days. Your dashboard fills with organic data from researchers already using your products on Clarida. Kit Intelligence: Activate - the platform fee and volume commitment are waived during the pilot. You pay only for the researcher analysis your researchers actually use, at the same per kit reaction rate as your post-pilot agreement. Adoption builds gradually during the pilot, so your pilot investment is modest. Your pilot data sets your post-pilot volume commitment - no guessing.

Anonymized, aggregated performance metrics only: Cq distributions, QC pass rates, instrument breakdowns, geographic patterns. Never individual results, gene names, sample identities, or researcher information. Full details in our privacy approach above.

Yes. Researchers explicitly opt in when selecting a partner kit during experiment setup, and can opt out at any time. They can optionally add a lot number to get lot-specific benchmarks in return. Privacy controls are built into the workflow, not buried in terms of service.

Each partner’s dashboard is scoped strictly to experiments involving their own products. When a researcher pairs your reagent with another partner’s product, you see the pairing as a chemistry category - “probe-optimized master mix” or “commercial pre-designed assay” - never a competitor’s brand name. Minimum aggregation thresholds prevent inference even in small categories. This is architecture-level isolation - the dashboard queries through a view layer that substitutes categories for brand names. Your competitor cannot see your experiment volume, performance data, or market share. You cannot see theirs.

Yes. Aggregated insights from your dashboard are yours to use: on your website, at conferences, in product documentation, or in investor presentations. For example: “Validated across CFX96, QuantStudio, LightCycler, StepOne, and more - in 40+ countries” - backed by real-world field data, not just internal testing. We’ll provide the data and help with framing.